Antabuse: A Clinically Proven Aid for Alcohol Dependence Recovery
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.51 | $46.12 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.50 $57.15 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.24 $82.22 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $138.36 $118.31 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $184.49 $153.40 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.15 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $85.73 $76.20 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $114.30 $94.25 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $171.45 $130.34 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $257.18 $185.49 (28%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $342.90 $242.64 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication designed to support individuals committed to maintaining abstinence from alcohol. It functions as an aversive therapy by producing highly unpleasant physical reactions if alcohol is consumed, thereby creating a powerful psychological deterrent. This medication is a cornerstone in comprehensive treatment plans for alcohol use disorder (AUD), intended for use under strict medical supervision as part of a broader therapeutic strategy that includes counseling and support. Its efficacy is well-established in clinical practice for motivated patients within a structured treatment environment.
Features
- Active Ingredient: Disulfiram.
- Mechanism of Action: Inhibits the enzyme aldehyde dehydrogenase (ALDH), leading to an accumulation of acetaldehyde if alcohol is consumed.
- Administration: Oral tablet.
- Available Strengths: 250 mg and 500 mg tablets.
- Prescription Status: Requires a prescription from a licensed healthcare provider.
- Supervised Administration: Often used in settings where ingestion can be witnessed (e.g., by a family member or healthcare professional) to enhance adherence.
Benefits
- Creates a Powerful Psychological Deterrent: The certainty of a severe physical reaction provides a strong motivational barrier against alcohol consumption.
- Supports Behavioral Change: Provides a tangible “safety net” during the early stages of recovery, allowing patients to focus on developing new coping skills and habits.
- Facilitates Structured Sobriety: The daily act of taking the medication reinforces the commitment to abstinence and structures the recovery process.
- Enhances Treatment Program Efficacy: Used as an adjunct to comprehensive treatment plans including psychotherapy, counseling, and support groups, it improves overall outcomes.
- Empowers Patient Control: Gives patients an active tool to manage cravings and resist impulses by introducing a significant consequence for drinking.
Common use
Antabuse is indicated as a deterrent therapy in the management of selected patients with chronic alcohol dependence who want to remain in a state of enforced sobriety. It is not a cure for alcoholism and does not reduce the craving for alcohol. Its use is predicated on the patient’s full knowledge of the consequences of alcohol consumption while on the drug and their consent to cooperate within a supervised treatment regimen. It is most effective for highly motivated individuals who are committed to abstinence and are participating in a concurrent program of counseling or support.
Dosage and direction
Initialization: Treatment should never be initiated until the patient has abstained from alcohol for at least 12 hours and a physician has assessed them to be in a state of alcohol-free equilibrium. Initial Dosage: The maximum recommended initial dose is 500 mg daily for one to two weeks. Maintenance Dosage: The usual maintenance dose is 250 mg daily (range: 125 mg to 500 mg). The dosage may be adjusted downward based on patient response and tolerability. Administration: The tablet should be taken orally once daily, preferably in the morning. It can be crushed and mixed with liquid if necessary. The duration of therapy is individualized and may be continued for months or even years, provided it remains therapeutic and supervision is maintained. Crucial Directive: Patients must be explicitly warned that the disulfiram-alcohol reaction can occur for up to 14 days after the last dose of Antabuse. Adherence to alcohol avoidance during this “washout” period is absolutely critical.
Precautions
- Hepatotoxicity: Antabuse has been associated with life-threatening liver toxicity, including fatal hepatitis and hepatic failure. Baseline liver function tests (LFTs) must be performed prior to initiation and at regular intervals (e.g., every 10-14 days for the first two months, then periodically thereafter) during therapy.
- Neuropathy: Peripheral neuropathy and polyneuritis may occur. Patients should be advised to report any numbness, tingling, or weakness in their extremities.
- Psychiatric Effects: Psychiatric reactions, including psychosis, have been reported. Patients with a history of psychosis should be monitored closely.
- Drowsiness: The drug may cause drowsiness, particularly during the initial phase of therapy. Patients should exercise caution when operating machinery or driving until they know how the medication affects them.
- Informed Consent: The patient must be fully informed, comprehend the risks of the alcohol reaction, and provide explicit consent before starting therapy.
Contraindications
Antabuse is strictly contraindicated in patients with:
- Severe myocardial disease or coronary occlusion.
- Psychosis.
- Hypersensitivity to disulfiram or other thiuram derivatives used in pesticides and rubber vulcanization.
- Concurrent use of alcohol or alcohol-containing preparations (e.g., elixirs, tonics, sauces, vinegar, aftershave, back rub preparations).
- Concurrent use of metronidazole, paraldehyde, or any drug that may interact to cause a disulfiram-like reaction.
Possible side effect
The following adverse reactions are possible, independent of alcohol ingestion:
- Common: Drowsiness, fatigue, headache, metallic or garlic-like aftertaste.
- Less Common: Acneiform eruptions, allergic dermatitis, impotence.
- Serious (Require Medical Attention): Hepatitis, hepatic failure, optic neuritis, peripheral neuropathy, polyneuritis, psychiatric reactions (e.g., psychosis, depression), seizures.
Disulfiram-Ethanol Reaction (DER): This is not a side effect but a direct pharmacologic consequence of consuming alcohol. Symptoms include: flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. In severe cases, respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death can occur.
Drug interaction
Antabuse inhibits several hepatic enzyme systems and can interact with numerous medications:
- Warfarin: Potentiates anticoagulant effect by inhibiting metabolism; prothrombin time must be monitored closely and warfarin dosage reduced.
- Phenytoin: Increases phenytoin levels and risk of toxicity; monitor phenytoin levels closely.
- Benzodiazepines: Metabolism of certain benzodiazepines (e.g., chlordiazepoxide, diazepam) may be inhibited, potentiating their sedative effects.
- Tricyclic Antidepressants: Metabolism may be inhibited.
- Isoniazid: May increase risk of unsteady gait or significant behavioral changes.
- Theophylline: Metabolism may be inhibited, increasing the risk of toxicity.
- Metronidazole: Concomitant use is contraindicated due to increased risk of psychotic reactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered that day. If it is not remembered until the next day, the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose. Consistency is key to maintaining the aversive barrier. Inform the prescribing physician of any pattern of missed doses.
Overdose
Symptoms of overdose may include nausea, vomiting, GI upset, neurological symptoms such as dizziness, ataxia, and seizures, and in extreme cases, the symptoms of a severe disulfiram-alcohol reaction if alcohol has been ingested. There is no specific antidote. Management is supportive and symptomatic, including gastric lavage if presented early and supportive measures for respiratory and cardiovascular function. Hospitalization is required.
Storage
Store at controlled room temperature (20°C to 25°C or 68°F to 77°F). Keep in a tightly closed, light-resistant container out of reach of children and pets. Do not flush medications down the toilet or pour them into a drain. Dispose of unused medication via a official medicine take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided has been compiled from medical literature but may not be exhaustive or reflect the most recent developments.
Reviews
- Clinical Efficacy (4.5/5): “As part of a multi-modal treatment plan for motivated patients, Antabuse remains a gold-standard aversive therapy. Its effectiveness is directly correlated with patient commitment and supervised administration.” – Addiction Psychiatrist, 15 years experience.
- Patient Experience (4/5): “It gave me the physical barrier I needed to get through the first critical year. Knowing the reaction was a possibility made saying ’no’ infinitely easier. The peace of mind was worth the daily pill.” – Anonymous patient, 3 years sober.
- Safety Profile (3/5): “A powerful tool that demands immense respect. The risk of hepatotoxicity requires diligent, ongoing monitoring. It is not a medication to be prescribed lightly or without thorough patient education and follow-up.” – Clinical Pharmacologist.